Peter Fernandes Email

CEO . Bellerophon

Current Roles

Employees:
17
Revenue:
$2.6M
About
Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Bellerophon Address
184 Liberty Corner Rd
Warren, NJ
United States

Past Companies

Bellerophon TherapeuticsChief Executive Officer
Bellerophon Therapeutics LLC (previously IKARIA, Inc.)Chief Regulatory, Safety & Quality Officer
Bellerophon TherapeuticsPrincipal Executive Officer / Chief Regulatory, Safety & Quality Officer

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.